Table 1.
Age (years) | Median: 55; range: 21–79 |
BMI (kg/m2) | Median: 23; range: 15–47 |
Menopausal status | |
Yes | 505 (60.3%) |
No | 333 (39.7%) |
Histology | |
Serous | 599 (71.5%) |
Mucous and others | 231 (28.5%) |
Differentiation | |
G1-2 | 420 (50.1%) |
G3 | 418 (49.9%) |
FIGO stage (2009) | |
I-II | 243 (29.0%) |
III-IV | 595 (71.0%) |
With lymphadenectomy | 631 (75.2%) |
Pelvic | 527 (83.5%) |
Para-aortic + pelvic | 104 (16.5%) |
Removed lymph nodes | Median: 25; range: 12–57 |
Lymph nodes metastasis | |
No | 642 (76.6%) |
Yes | 196 (23.4%) |
Residual disease | |
<1 cm | 631 (75.3%) |
≥1 cm | 207 (24.7%) |
Ascites volume (mL) | Median: 1000; range: 0–7000 |
≤1000 | 591 (70.5%) |
>1000 | 247 (29.5%) |
Serum CA125 (U/mL) | Median: 675; range: 23–7400 |
≤675 | 521 (62.2%) |
>675 | 317 (37.8%) |
Tumor-stroma ratio (TSR) | |
Stroma-poor (TSR < 50%) | 575 (68.6%) |
Stroma-rich (TSR ≥ 50%) | 263 (31.4%) |